This new report, World Market for Blood Screening, focuses on the evolving, multibillion-dollar global blood screening market. Blood screening is a medical process that scans blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations.
Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in the blood supply, determine the causes of transfusion reactions of unknown etiology, assess the effectiveness of new donor screening methods, and evaluate the donation process to improve the adequacy of the blood supply.
Blood screening diagnostic markets are driven primarily by the aging of developed markets, new test applications and emerging markets, with the last probably the most important factor in an otherwise low-growth category. As developing nations decide to increase blood safety measures, NAT testing will drive growth in the market.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
OVERVIEW OF BLOOD SCREENING DIAGNOSTICS
MARKET OUTLOOK
- Figure 1-1: Blood Donation Screening Market Distribution by Analyte, 2021
- Figure 1-2: Whole Blood Donations per 1000 Population, 2013
Major Product Activity
Immunoassay
CHAPTER 2: BLOOD SCREENING MARKET
- Figure 2-1: Blood Screening Market, 2016 – 2026 ($B)
- Figure 2-2: Policy Adoption of NAT for Blood Screening of HCV, HBV and HIV by Select Country
IMMUNOASSAY AND NUCLEIC ACID TESTING (NAT) MARKETS
- Figure 2-3: Blood Screening Sales by Test Method (Immunoassay vs. NAT), 2021 and 2026 ($B)
REGIONAL MARKET
- Table 2-1: Blood Screening Market Distribution by Global Region, 2021 (North America, Europe, Asia Pacific, RoW)
- Table 2-2: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
- Table 2-3: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
OTHER TRENDS
COVID-19
Zika Virus
Blood and Component Collection
- Table 2-4: Blood Component Usage for Selected Conditions
- Table 2-5: Red Blood Cell and Platelet Use by Hospital Services (%)
COVID-19 Impact on Plasma Collection
Reevaluating Blood Transfusions
- Table 2-6: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
CHAPTER 3: BLOOD TYPING AND GROUPING MARKET
Manual Blood Typing Methods
Automated Blood Typing and Screening Methods
Molecular Methods
Reducing Blood Typing Errors
- Table 3-1: Selected Blood Typing and Grouping Innovations
Size and Growth of Typing Markets
- Table 3-2: Global Blood Typing Market, 2021-2026 (Typing) (in $ millions)
Blood Typing Market by Geography
- Table 3-3: Global Blood Typing Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
CHAPTER 4: TOP COMPANY BRIEFS
ABBOTT DIAGNOSTICS
CERUS CORPORATION
- COVID-19
GRIFOLS S.A.
ORTHO CLINICAL DIAGNOSTICS (ORTHO)
- Blood Bank
- Avioq and Ortho Clinical
QUOTIENT LIMITED
COVID-19
ROCHE
- Blood Bank
Samples
LOADING...
Companies Mentioned
- Abbott Diagnostics
- Cerus Corporation
- Grifols S.A.
- Ortho Clinical Diagnostics (Ortho)
- Quotient Limited
- Roche
